BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21885611)

  • 21. A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicin.
    Trucco M; Barredo JC; Goldberg J; Leclerc GM; Hale GA; Gill J; Setty B; Smith T; Lush R; Lee JK; Reed DR
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27224. PubMed ID: 29856514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial.
    Domenech C; Suciu S; De Moerloose B; Mazingue F; Plat G; Ferster A; Uyttebroeck A; Sirvent N; Lutz P; Yakouben K; Munzer M; Röhrlich P; Plantaz D; Millot F; Philippet P; Dastugue N; Girard S; Cavé H; Benoit Y; Bertrandfor Y;
    Haematologica; 2014 Jul; 99(7):1220-7. PubMed ID: 24727815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populations.
    Yang W; Devidas M; Liu Y; Smith C; Dai Y; Winick N; Hunger SP; Loh ML; Raetz EA; Larsen EC; Carroll WL; Winter SS; Dunsmore KP; Mattano LA; Relling MV; Karol SE
    Blood; 2021 Mar; 137(11):1550-1552. PubMed ID: 33106839
    [No Abstract]   [Full Text] [Related]  

  • 24. [Efficacy observation of polyethylene glycol conjugated asparaginase for induction treatment of children with newly diagnosed acute lymphoblastic leukemia].
    Liu F; Wan Y; Chang L; Guo Y; Yang W; Wang S; Chen X; Liu T; Ruan M; Zhang L; Liu X; Zou Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):215-7. PubMed ID: 24824393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asparagine concentration in plasma after 2,500 IU/m(2) PEG-asparaginase i.v. in children with acute lymphoblastic leukemia.
    Wenner KA; Vieira Pinheiro JP; Escherich G; Wessalowski R; Jorch N; Wolff J; Stehn M; Kohlschütter A; Boos J; Janka-Schaub GE
    Klin Padiatr; 2005; 217(6):321-6. PubMed ID: 16307417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe hypertriglyceridemia in a 6-year-old boy with ALL relapse: successfully treated with plasmapheresis.
    Winkler B; Kuhn S; Kunzmann S; Ruf K; Wiegering V; Schlegel PG
    Klin Padiatr; 2013 Nov; 225(6):364-5. PubMed ID: 24158897
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.
    Kawedia JD; Kaste SC; Pei D; Panetta JC; Cai X; Cheng C; Neale G; Howard SC; Evans WE; Pui CH; Relling MV
    Blood; 2011 Feb; 117(8):2340-7; quiz 2556. PubMed ID: 21148812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.
    te Winkel ML; Pieters R; Hop WC; de Groot-Kruseman HA; Lequin MH; van der Sluis IM; Bökkerink JP; Leeuw JA; Bruin MC; Egeler RM; Veerman AJ; van den Heuvel-Eibrink MM
    J Clin Oncol; 2011 Nov; 29(31):4143-50. PubMed ID: 21947829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Avascular necrosis of the right elbow occuring while on UKALL 2003 protocol.
    Francis S; Johnson K; Darbyshire P
    Eur J Haematol; 2008 Aug; 81(2):164. PubMed ID: 18363872
    [No Abstract]   [Full Text] [Related]  

  • 30. A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
    Welte K; Reiter A; Mempel K; Pfetsch M; Schwab G; Schrappe M; Riehm H
    Blood; 1996 Apr; 87(8):3143-50. PubMed ID: 8605328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia.
    Badhiwala JH; Nayiager T; Athale UH
    Pediatr Blood Cancer; 2015 Oct; 62(10):1851-4. PubMed ID: 25931304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Avascular necrosis of bone after adult acute lymphocytic leukemia treatment with methotrexate, vincristine, L-asparaginase, and dexamethasone (MOAD).
    Hui L; Wiernik PH
    Am J Hematol; 1996 Jul; 52(3):184-8. PubMed ID: 8756084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive chemotherapy for acute lymphoblastic leukaemia in adults.
    Rohatiner AZ; Bassan R; Battista R; Barnett MJ; Gregory W; Lim J; Amess J; Oza A; Barbui T; Horton M
    Haematol Blood Transfus; 1990; 33():413-8. PubMed ID: 2182432
    [No Abstract]   [Full Text] [Related]  

  • 34. [The programmed therapy of acute lymphoblastic leukemia in adults].
    Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
    Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
    [No Abstract]   [Full Text] [Related]  

  • 35. Venoocclusive disease due to chemotherapy for pediatric acute lymphoblastic leukemia is associated with increased levels of plasminogen-activator inhibitor-1.
    Mauro M; Saggiorato G; Sartori MT; Gallo G; De Bortoli M; Bonetti E; Zaccaron A; Vitale V; Balter R; Chinello M; Cesaro S
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26963. PubMed ID: 29350496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.
    Vrooman LM; Stevenson KE; Supko JG; O'Brien J; Dahlberg SE; Asselin BL; Athale UH; Clavell LA; Kelly KM; Kutok JL; Laverdière C; Lipshultz SE; Michon B; Schorin M; Relling MV; Cohen HJ; Neuberg DS; Sallan SE; Silverman LB
    J Clin Oncol; 2013 Mar; 31(9):1202-10. PubMed ID: 23358966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia.
    Lowas SR; Marks D; Malempati S
    Pediatr Blood Cancer; 2009 Jul; 52(7):814-8. PubMed ID: 19260096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteonecrosis in children treated for acute leukemia.
    Pediatric Hematology Working Group of the Czech Republic and Collaborators
    Med Pediatr Oncol; 1999 Jun; 32(6):474-6. PubMed ID: 10358717
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of children with relapsed and refractory acute lymphoblastic leukemia with mitoxantrone, vincristine, pegaspargase, dexamethasone, and bortezomib.
    August KJ; Guest EM; Lewing K; Hays JA; Gamis AS
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28062. PubMed ID: 31724803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. British OsteoNEcrosis Study (BONES) protocol: a prospective cohort study to examine the natural history of osteonecrosis in older children, teenagers and young adults with acute lymphoblastic leukaemia and lymphoblastic lymphoma.
    Amin N; Kinsey S; Feltbower R; Kraft J; Whitehead E; Velangi M; James B
    BMJ Open; 2019 May; 9(5):e027204. PubMed ID: 31122988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.